Search details
1.
Hydroxychloroquine for Primary Progressive Multiple Sclerosis.
Ann Neurol
; 90(6): 940-948, 2021 12.
Article
in English
| MEDLINE | ID: mdl-34590328
2.
Minocycline treatment in clinically isolated syndrome and serum NfL, GFAP, and metalloproteinase levels.
Mult Scler
; 28(13): 2081-2089, 2022 Nov.
Article
in English
| MEDLINE | ID: mdl-35848622
3.
Trial of Minocycline in a Clinically Isolated Syndrome of Multiple Sclerosis.
N Engl J Med
; 376(22): 2122-2133, 2017 06 01.
Article
in English
| MEDLINE | ID: mdl-28564557
4.
Feasibility study to assess lesion repair in relapsing-remitting multiple sclerosis: A randomized controlled pilot clinical trial of domperidone add-on treatment.
Mult Scler Relat Disord
; 85: 105525, 2024 May.
Article
in English
| MEDLINE | ID: mdl-38461731
5.
Repurposing Domperidone in Secondary Progressive Multiple Sclerosis: A Simon 2-Stage Phase 2 Futility Trial.
Neurology
; 96(18): e2313-e2322, 2021 05 04.
Article
in English
| MEDLINE | ID: mdl-34038379
6.
Assessing the efficacy and safety of hydroxychloroquine as outpatient treatment of COVID-19: a randomized controlled trial.
CMAJ Open
; 9(2): E693-E702, 2021.
Article
in English
| MEDLINE | ID: mdl-34145052
7.
Multimodal peripheral fluid biomarker analysis in clinically isolated syndrome and early multiple sclerosis.
Mult Scler Relat Disord
; 50: 102809, 2021 May.
Article
in English
| MEDLINE | ID: mdl-33581614
8.
A novel biological activity for galectin-1: inhibition of leukocyte-endothelial cell interactions in experimental inflammation.
Am J Pathol
; 163(4): 1505-15, 2003 Oct.
Article
in English
| MEDLINE | ID: mdl-14507657
Results
1 -
8
de 8
1
Next >
>>